[
  {
    "ts": null,
    "headline": "CVS Health Entering 2026 With Momentum and Visibility Into Mid-Teens EPS Growth Through 2028, RBC Says",
    "summary": "CVS Health (CVS) is entering 2026 with momentum and visibility into mid-teens earnings growth throug",
    "url": "https://finnhub.io/api/news?id=8ee971e277b3ed9c3ce0ec25ea54a572f23004d1e7f204c0298730bccf35f3fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765384311,
      "headline": "CVS Health Entering 2026 With Momentum and Visibility Into Mid-Teens EPS Growth Through 2028, RBC Says",
      "id": 137750428,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) is entering 2026 with momentum and visibility into mid-teens earnings growth throug",
      "url": "https://finnhub.io/api/news?id=8ee971e277b3ed9c3ce0ec25ea54a572f23004d1e7f204c0298730bccf35f3fa"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Lifts Long-Term Growth Targets on PCW Profitability, Turnaround Progress, Morgan Stanley Says",
    "summary": "CVS Health (CVS) is highlighting clearer long-term earnings prospects and solid performance across i",
    "url": "https://finnhub.io/api/news?id=dc9ba8cbc3ed8389cd9860c691f7c31a66dd6bc088382cb88c1941b19d275c01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765383315,
      "headline": "CVS Health Lifts Long-Term Growth Targets on PCW Profitability, Turnaround Progress, Morgan Stanley Says",
      "id": 137750429,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) is highlighting clearer long-term earnings prospects and solid performance across i",
      "url": "https://finnhub.io/api/news?id=dc9ba8cbc3ed8389cd9860c691f7c31a66dd6bc088382cb88c1941b19d275c01"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures",
    "summary": "CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to $86.00 from $77.00, while reaffirming a ‘Market Perform’ rating on the stock. The firm attributed the improved guidance to the company’s Aetna business unit, […]",
    "url": "https://finnhub.io/api/news?id=e4f640e9979a506d13824d4b24dfb216401844dfa188b86a56cc688ba53af1d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765380787,
      "headline": "CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures",
      "id": 137750430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to $86.00 from $77.00, while reaffirming a ‘Market Perform’ rating on the stock. The firm attributed the improved guidance to the company’s Aetna business unit, […]",
      "url": "https://finnhub.io/api/news?id=e4f640e9979a506d13824d4b24dfb216401844dfa188b86a56cc688ba53af1d7"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Maintains CVS Health (CVS) Overweight Recommendation",
    "summary": "Morgan Stanley Maintains CVS Health (CVS) Overweight Recommendation",
    "url": "https://finnhub.io/api/news?id=b756d9cfe2d1302af33d2f71881e2eeef8f570ae7f02d31f1b3b742df1618517",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765379450,
      "headline": "Morgan Stanley Maintains CVS Health (CVS) Overweight Recommendation",
      "id": 137747712,
      "image": "",
      "related": "CVS",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b756d9cfe2d1302af33d2f71881e2eeef8f570ae7f02d31f1b3b742df1618517"
    }
  },
  {
    "ts": null,
    "headline": "Baird Maintains CVS Health (CVS) Outperform Recommendation",
    "summary": "Baird Maintains CVS Health (CVS) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=56ac08fb4a1f31178d8fe92522088ec6de7bda683f4903558016b9eefe3e6e2f",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765379449,
      "headline": "Baird Maintains CVS Health (CVS) Outperform Recommendation",
      "id": 137747713,
      "image": "",
      "related": "CVS",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=56ac08fb4a1f31178d8fe92522088ec6de7bda683f4903558016b9eefe3e6e2f"
    }
  },
  {
    "ts": null,
    "headline": "Mizuho Maintains CVS Health (CVS) Outperform Recommendation",
    "summary": "Mizuho Maintains CVS Health (CVS) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=94e614f23dd03913577d531fdcee4b7fe57af4408e4a08e7b1bb2b1dc8e2c949",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765379447,
      "headline": "Mizuho Maintains CVS Health (CVS) Outperform Recommendation",
      "id": 137747714,
      "image": "",
      "related": "CVS",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=94e614f23dd03913577d531fdcee4b7fe57af4408e4a08e7b1bb2b1dc8e2c949"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript",
    "summary": "CVS Health Corporation (CVS) Analyst/Investor Day December 9, 2025 8:00 AM ESTCompany ParticipantsLarry McGrath - Executive VP, Chief Strategy Officer &...",
    "url": "https://finnhub.io/api/news?id=1ba8be4814c7f3dc3ce9a8b57908a9802b64c7572721bb5e1c2a9dc4be759c38",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765370569,
      "headline": "CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript",
      "id": 137748646,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "CVS Health Corporation (CVS) Analyst/Investor Day December 9, 2025 8:00 AM ESTCompany ParticipantsLarry McGrath - Executive VP, Chief Strategy Officer &...",
      "url": "https://finnhub.io/api/news?id=1ba8be4814c7f3dc3ce9a8b57908a9802b64c7572721bb5e1c2a9dc4be759c38"
    }
  },
  {
    "ts": null,
    "headline": "CVS to launch ‘engagement’ platform in gamble on consumer, industry interest",
    "summary": "CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products and services as well. The goal is to improve consumers’ health engagement while generating more revenue.",
    "url": "https://finnhub.io/api/news?id=5ebb485ee925badbe6a07576d49743bdaa78f09727bb5877b74b98b951468893",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765364352,
      "headline": "CVS to launch ‘engagement’ platform in gamble on consumer, industry interest",
      "id": 137750431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products and services as well. The goal is to improve consumers’ health engagement while generating more revenue.",
      "url": "https://finnhub.io/api/news?id=5ebb485ee925badbe6a07576d49743bdaa78f09727bb5877b74b98b951468893"
    }
  },
  {
    "ts": null,
    "headline": "Cramer’s Stop Trading: CVS Health",
    "summary": "CNBC’s Jim Cramer explains why he is keeping an eye on shares of CVS Health.",
    "url": "https://finnhub.io/api/news?id=c0c9f457f399d6e8ee0ee786bef21dd1ec16c4e82807fa327668daf0218b46f1",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765362327,
      "headline": "Cramer’s Stop Trading: CVS Health",
      "id": 137748413,
      "image": "https://image.cnbcfm.com/api/v1/image/108239833-17653801691765380167-42917287918-1080pnbcnews.jpg?v=1765380168&w=1920&h=1080",
      "related": "CVS",
      "source": "CNBC",
      "summary": "CNBC’s Jim Cramer explains why he is keeping an eye on shares of CVS Health.",
      "url": "https://finnhub.io/api/news?id=c0c9f457f399d6e8ee0ee786bef21dd1ec16c4e82807fa327668daf0218b46f1"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Shifts Are Rewriting the Story for CVS Health",
    "summary": "CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth assumptions. While the discount rate has ticked up from around 7.18% to about 7.35%, reflecting a marginally higher required return amid lingering industry risks, updated research still leans constructive given improving earnings visibility and expectations for medium term margin recovery. Stay...",
    "url": "https://finnhub.io/api/news?id=1d19b33e9d5f1617dfcdb1125ea544d56fdac8a9dfca982b6f38d26f624bc922",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765357944,
      "headline": "How Recent Shifts Are Rewriting the Story for CVS Health",
      "id": 137750432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth assumptions. While the discount rate has ticked up from around 7.18% to about 7.35%, reflecting a marginally higher required return amid lingering industry risks, updated research still leans constructive given improving earnings visibility and expectations for medium term margin recovery. Stay...",
      "url": "https://finnhub.io/api/news?id=1d19b33e9d5f1617dfcdb1125ea544d56fdac8a9dfca982b6f38d26f624bc922"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons CVS is Risky and 1 Stock to Buy Instead",
    "summary": "CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=fb5190771e554bc9c4cdc3dffaded97712b1523877d89df63ebe2764f2b8cf66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765339373,
      "headline": "3 Reasons CVS is Risky and 1 Stock to Buy Instead",
      "id": 137750433,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=fb5190771e554bc9c4cdc3dffaded97712b1523877d89df63ebe2764f2b8cf66"
    }
  },
  {
    "ts": null,
    "headline": "CVS shares jump on raised profit outlook for 2025",
    "summary": "STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATESShares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.He added, \"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust.\"The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.CVS shares have responded with gains of more than 70% this year.CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.Analysts at Leerink Partners said in a note that, \"CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”",
    "url": "https://finnhub.io/api/news?id=17c49b5a1928846c4382b844f4bd3a3c326942c2a4025c027fcd6b0ddc83e779",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765334964,
      "headline": "CVS shares jump on raised profit outlook for 2025",
      "id": 137750434,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "STORY: EDITOR'S NOTE:THIS STORY WAS REFILED TO CORRECT A LINE SAYING THE COMPANY'S PROFIT FORECAST TOPPED ESTIMATESShares of CVS rose as much as five percent Tuesday morning after the company raised its 2025 profit outlook for the fourth time.CEO David Joyner said at the company’s investor day that CVS has delivered on its promises this year and will now focus on improving consumer experiences across the business.He added, \"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust.\"The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, which involved cutting costs, exiting underperforming markets, and strengthening management to revive investor confidence.CVS shares have responded with gains of more than 70% this year.CVS said in May that it plans to exit the market for Obamacare health insurance plans in 2026, as rising medical costs have pressured health insurers in recent quarters.The company expects its Aetna insurance business and CVS Caremark pharmacy benefit management unit to drive growth, as their profit margins are expected to return to target levels.Analysts at Leerink Partners said in a note that, \"CVS' near-term momentum should set the stage for what remains a robust growth recovery story.”",
      "url": "https://finnhub.io/api/news?id=17c49b5a1928846c4382b844f4bd3a3c326942c2a4025c027fcd6b0ddc83e779"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow",
    "summary": "2025-12-10. The following slide deck was published by CVS Health Corporation in conjunction with this event.",
    "url": "https://finnhub.io/api/news?id=42265b5a8cbaea7f548c2e2c6d359a4a745c2483893418af2ed1cb5d491ab305",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765325700,
      "headline": "CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow",
      "id": 137745225,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "2025-12-10. The following slide deck was published by CVS Health Corporation in conjunction with this event.",
      "url": "https://finnhub.io/api/news?id=42265b5a8cbaea7f548c2e2c6d359a4a745c2483893418af2ed1cb5d491ab305"
    }
  }
]